TSE:4502Pharmaceuticals
Takeda Pharmaceutical (TSE:4502) Prepares For Leadership Transition With New Executives
Takeda Pharmaceutical (TSE:4502) recently announced significant leadership changes, with Rhonda Pacheco joining as President of the U.S. Business Unit and Julie Kim preparing for a CEO transition. These moves align with broader market gains, where indices reached record highs amid anticipation of Federal Reserve rate cuts following consumer inflation reports. Takeda's stock rose 4% over the past month, paralleling a 19% annual increase in the broader market. During the month, Takeda also...